Certara announced that CFO John Gallagher will resign effective July 14, 2026. Faiz Mohammed, Senior VP of Finance, will serve as interim CFO while the company searches for a permanent replacement. Despite the leadership change, Certara reaffirmed its financial guidance for 2026, signaling confidence in its business outlook. This transition comes as Certara continues to lead in model-informed drug development globally.
Ultragenyx Pharmaceutical Inc. awarded 44,409 restricted stock units to 15 newly hired non-executive officers under its Employment Inducement Plan. The grants, approved by the compensation committee, vest over four years with 25% vesting annually, co...
Nyxoah has announced an extraordinary general meeting of shareholders set for July 9, 2026, at its headquarters in Belgium. The meeting will discuss renewing the authorization for the board to increase the company's capital over the next five years, ...
Eupraxia Pharmaceuticals held its Annual General Meeting on June 18, 2026, where shareholders elected all seven board nominees proposed by management with strong majority votes. Additionally, KPMG LLP was reappointed as the company's auditor for the ...
Cate & Chloe is discounting its Bianca 18k Gold-Plated Crystal Hoop Earrings to $19.98 from $86 during Amazon Prime Day 2026, running June 23-26. This 77% markdown aligns with growing consumer demand for affordable luxury jewelry, with earrings price...
Solana's price has pulled back sharply and is now testing a crucial support zone between $60 and $65 after failing to break higher resistance levels. This area is critical for traders as it could determine whether the price stabilizes or continues to...
